RIOX2 and mucinous adenocarcinoma: A detailed analysis clearly demonstrates increased expression of mdig in early stages of breast cancers and in noninvasive breast cancers, including medullary carcinoma, DCIS and mucinous carcinoma (Fig. 6g, h).